Integral Molecular News

Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes

FOX, ET AL. 2019. SCI IMMUNOL, 4(32): EAAV5062

Read More

Upcoming Events

 
Antibody Engineering & Therapeutics
12/4 – 12/8 | San Diego, California